Medical Devices

A Cairo hospital's innovative model earns global praise, using revenue from international patients to provide free, world-class cancer care for children.

Henlius and Organon's POHERDY gains EC approval, set to expand access and lower costs for a critical breast cancer therapy across the European Union.

A novel topical gel that boosts cellular energy is now in late-stage trials, offering new hope for healing the chronic wounds of diabetic foot ulcers.

New MD Andreas Goppelt brings a bold M&A and digital transformation agenda to OrphaCare, aiming to reshape rare disease patient care globally.

While the global glove industry faced oversupply and price wars, INTCO Medical achieved a four-year revenue high through strategic innovation and expansion.

Genomics' big data and Greywolf's novel drugs unite to develop first-in-class treatments for autoimmune diseases, promising a new era of precision medicine.

A landmark study reveals a hidden genetic cause for a common kidney disease in adults, urging for expanded genetic screening and paving the way for new therapies.

Hypervision Surgical's AI platform gives surgeons real-time tissue data invisible to the eye. A new investment aims to bring this tech to operating rooms.

With a solid 2025 behind them, investors are watching Bioventus's Q1 results for signs of continued momentum in innovation and profitability.

Cordis launches the first sirolimus-eluting balloon for peripheral artery disease in Japan, backed by strong 3-year clinical data showing durable results.

With financials improving but competition rising, medical device maker Pulmonx faces a critical audience at the BofA healthcare conference in May.

A new at-home testing system aims to unite dentists and physicians, streamlining obstructive sleep apnea treatment for millions of undiagnosed patients.

With expanded FDA clearance for its ARx SAI system, Life Spine challenges the closed-system model, offering surgeons unprecedented cross-vendor flexibility.

The pharma giant reports a net loss after a major write-down, but management points to a strong consumer division and a CDMO rebound as signs of recovery.

The Aesthetic Show returns to Vegas, blending AI and regenerative science with a focus on inclusivity, professional growth, and philanthropic purpose.

A Dubai hospital pioneers a one-time gene therapy for an adult with SMA, offering new hope to a patient population previously left with limited options.

A landmark study shows a novel device can safely treat severe artery blockages below the ankle, offering new hope for patients at risk of amputation.

Vensica Medical gets FDA clearance for a Phase 2 study of its ultrasound device that delivers botulinum toxin without needles for overactive bladder.

A new HHS agenda reopens the door for controversial peptides, just as a wave of next-gen obesity drugs threatens to upend the entire market.

A new wearable using ultrasound resonance could finally solve the accuracy and calibration problems plaguing blood pressure monitors for a billion patients.